Healthlead PCL (BKK:HL) Shares Outstanding (EOP): 256 Mil (As of Mar. 2026)


BKK:HL Healthlead PCL BKK:HL
72 GF Score
Price ฿5.75
GF Value ฿10.87
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is Healthlead PCL Shares Outstanding (EOP)?

Healthlead PCL BKK:HL 72 Shares Outstanding (EOP) is 256 Mil as of Mar. 2026. GuruFocus rates BKK:HL with a GF Score™ of 72/100 and a GF Value™ of ฿10.87 (Significantly Undervalued). The stock has 3 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. Healthlead PCL's shares outstanding for the quarter that ended in Mar. 2026 was 256 Mil.

Healthlead PCL's quarterly shares outstanding declined from Dec. 2025 (270 Mil) to Mar. 2026 (256 Mil). It means Healthlead PCL bought back shares from Dec. 2025 to Mar. 2026 .

Healthlead PCL's annual shares outstanding declined from Dec. 2024 (272 Mil) to Dec. 2025 (270 Mil). It means Healthlead PCL bought back shares from Dec. 2024 to Dec. 2025 .


Healthlead PCL  (BKK:HL) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


Healthlead PCL Shares Outstanding (EOP) Related Terms


Healthlead PCL Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for Healthlead PCL's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Healthlead PCL Shares Outstanding (EOP) Chart

Healthlead PCL Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial 272.00 272.00 272.00 272.00 270.29

Healthlead PCL Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 272.00 267.69 266.48 270.29 256.49

Healthlead PCL Shares Outstanding (EOP) Competitor Comparison

For the Pharmaceutical Retailers subindustry, Healthlead PCL's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Healthlead PCL Shares Outstanding (EOP) vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Healthlead PCL's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where Healthlead PCL's Shares Outstanding (EOP) falls into.


BKK:HL
72GF Score
Healthlead PCL BKK:HL
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Healthlead PCL Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 256 Mil mean?
Healthlead PCL (BKK:HL) has a Shares Outstanding (EOP) of 256 Mil as of Mar. 2026. The total shares a company has outstanding, at period-end. View historical data on Healthlead PCL and its competitors.
Is Healthlead PCL's Shares Outstanding (EOP) too high?
Healthlead PCL's current Shares Outstanding (EOP) is 256 Mil. Overall, Healthlead PCL has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Healthlead PCL's Shares Outstanding (EOP) compare to competitors?
Healthlead PCL's Shares Outstanding (EOP) of 256 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for a Healthcare Providers & Services company?
A good Shares Outstanding (EOP) depends on the Healthcare Providers & Services industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on Healthlead PCL and its competitors. Healthlead PCL's current Shares Outstanding (EOP) is 256 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Healthlead PCL stock overvalued right now?
Based on GuruFocus' analysis, Healthlead PCL (BKK:HL) is currently considered Significantly Undervalued. The stock's GF Value™ is ฿10.87, compared to a current price of ฿5.75 — trading 47.1% below its estimated fair value. The current Shares Outstanding (EOP) is 256 Mil. Healthlead PCL's overall GF Score™ is 72/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For Healthlead PCL (BKK:HL), the current Shares Outstanding (EOP) is 256 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Healthlead PCL (BKK:HL) Overvalued in 2026?

Based on GuruFocus' analysis, Healthlead PCL stock appears to be undervalued. The current stock price of ฿5.75 is trading 47.1% below its estimated GF Value™ of ฿10.87. GuruFocus considers Healthlead PCL to be Significantly Undervalued.

Key valuation signals for BKK:HL:

  • Shares Outstanding (EOP): 256 Mil
  • GF Value™: ฿10.87 vs. price of ฿5.75 (47.1% below fair value)
  • GF Score™: 72/100 with 3 warning signs

No single metric tells the full story. See the BKK:HL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Healthlead PCL Business Description

Address 99/4 Moo 10, Bang Muang Sub-District, Bang-Yai District, Nonthaburi, THA, 11140
Healthlead PCL is a holding company. Along with its subsidiaries, it operates a pharmacy business under iCare, Pharmax, vitaminclub, and Super Drug brands, distributing medicines, medical supplies, cosmeceuticals, dietary supplements, medical devices, and other healthcare products. Additionally, it is involved in co-inventing and co-developing healthcare products in collaboration with external research teams and contract manufacturers, producing and distributing its own branded products. Geographically, the group operates only in Thailand.
72GF Score

Get the complete analysis for BKK:HL

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿5.75
Price
฿10.87
GF Value